A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

NCT02553187 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Cancer Cachexia

Interventions

DRUG: Kanglaite Injection

Sponsor

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Collaborators

[object Object]